[#ASGCT23] Wednesday, May 17, 12 pm – 2 pm: Marine Laurent, from Gene Editing team of @GenethonFr will present a poster: 📄Learn more on #GeneTherapy for LAL-D patient with #AAV vectors.
👉 In Vivo Gene Therapy for Lysosomal Acid Lipase Deficiency [Board No. 643]
[#ASGCT23] Wednesday, May 17, Ana Buj-Bello, M.D., Ph.D., MBA, leader of the Neuromuscular Diseases and #GeneTherapy Team, of @GenethonFr, is co-chair of the oral abstract session on #AAV Vectors – Clinical/Nonhuman primate studies, from 3:45 pm – 5:30 pm US PDT (Rm 411).
[#ASGCT23] Wednesday, May 17, 12 pm – 2 pm: Alexandra Tachtsidi, from Gene Editing team of @GenethonFr will present a poster:
👉Characterization and Quantification of CRISPR/Cas9-Induced Genomic Alterations and AAV Targeted Integration in Human HSPC [Board No. 527]
#ESGCT2022 - Want to know more about @GenethonFr's work? Come and meet @atachtsidi (P92), Pauline Vidal (P450), and Guillaume Corre (P628) at the @ESGCT meeting poster session. They're here to answer your questions until 7 PM!
It's today! The @ESGCT meeting is taking place in Edinburgh until Friday. Our @GenethonFr researchers will present our latest advance in #GeneTherapy for #RareDiseases.
Find out more about our presentations: https://t.co/Yubkpenpmu